Profiling and assessing the risks of image- and performance-enhancing drugs use during the COVID-19 lockdown.  De Luca I, Di Carlo F, Burkauskas J, Dores AR, Carvalho IP, Gómez-Martínez MÁ, Szabo A, Fujiwara H, Barbosa CM, Di Nicola M, Mazza...

Factors associated with SARS-CoV-2 testing, diagnosis and COVID-19 disease among individuals prescribed opioid-agonist treatment: a nationwide retrospective cohort study.  Glancy M, Yeung A, McAuley A, Palmateer N, Bishop J, Taylor B, Lang J...

Police-referred psychiatric emergency presentations during the first and second wave of COVID-19 in Berlin, Germany: a retrospective chart review.  Goldschmidt T, Kippe YD, Gutwinski S, Deutscher K, Schouler-Ocak M, Kroehn-Liedtke F.  ...

Consumption of illicit drugs and benzodiazepines in six Spanish cities during different periods of the COVID-19 pandemic.  Gracia-Lor E, Pérez-Valenciano A, De Oro-Carretero P, Ramírez-García L, Sanz-Landaluze J, Martín-Gutiérrez MJ.  ...

The impact of the COVID-19 pandemic on people who use drugs in three Canadian cities: a cross-sectional analysis.  Mitra S, Bouck Z, Larney S, Zolopa C, Høj S, Minoyan N, Upham K, Rammohan I, Mok WY, Hayashi K, Milloy MJ, DeBeck K, Scheim A,...

Determinants of psychological distress during the COVID-19 pandemic among people who use drugs in Montreal, Canada.  Makarenko I, Minoyan N, Bordier Høj S, Udhesister S, Martel-Laferrière V, Jutras-Aswad D, Larney S, Bruneau J.  Drug A...